Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action.
暂无分享,去创建一个
J. Seidman | H. Watkins | C. Seidman | H. Sweeney | H. Feng | H S Feng
[1] I. Rayment,et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle , 1996, Nature Genetics.
[2] J. Seidman,et al. Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.
[3] J. Beckmann,et al. Cardiac myosin binding protein–C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy , 1995, Nature Genetics.
[4] J. Seidman,et al. Familial hypertrophic cardiomyopathy: a genetic model of cardiac hypertrophy. , 1995, Human molecular genetics.
[5] T. Imaizumi,et al. A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. , 1995, Circulation.
[6] K. Schwartz. Familial hypertrophic cardiomyopathy. Nonsense versus missense mutations. , 1995, Circulation.
[7] J. Seidman,et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.
[8] L. Fananapazir,et al. Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. , 1995, The Journal of clinical investigation.
[9] Christine E. Seidman,et al. α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.
[10] L. Leinwand,et al. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. , 1994, The Journal of biological chemistry.
[11] J. Sadoshima,et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro , 1993, Cell.
[12] W. Zhu,et al. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. , 1993, The Journal of clinical investigation.
[13] J. Seidman,et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.
[14] S. Chien,et al. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] J. Seidman,et al. A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.
[16] P. Anderson,et al. Functions of the myosin ATP and actin binding sites are required for C. elegans thick filament assembly , 1990, Cell.
[17] M. Davies. The current status of myocardial disarray in hypertrophic cardiomyopathy. , 1984, British heart journal.
[18] L. Tobacman,et al. Thin filament-mediated regulation of cardiac contraction. , 1996, Annual review of physiology.
[19] T. Parker,et al. Growth factors, proto-oncogenes, and plasticity of the cardiac phenotype. , 1991, Annual review of physiology.
[20] Y. Nonomura,et al. Electron microscopic and electrophoretic studies of a Drosophila muscle mutant wings-up B , 1981 .